Activation of oncogenic pathways in degenerating neurons in Alzheimer disease

International Journal of Developmental Neuroscience

Volumn 18, Issue 4-5, 2000, Pages 433-437

  Zhu, Xiongwei ^a   Raina, Arun K ^a   Boux, Heather ^b   Simmons, Zachary L ^a   Takeda, Atsushi ^a   Smith, Mark A ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b StressGen Biotechnologies Corp   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; ARTICLE; CELL CYCLE; CELL DIVISION; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; NERVE DEGENERATION; NERVOUS SYSTEM DEVELOPMENT; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CDC42 GTP-BINDING PROTEIN; HIPPOCAMPUS; HUMANS; MIDDLE AGED; NERVE DEGENERATION; NEURONS; ONCOGENES; RAC GTP-BINDING PROTEINS; SIGNAL TRANSDUCTION;

EID: 0034237405     PISSN: 07365748     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0736-5748(00)00010-1     Document Type: Article

References (45)

1. Masliah E., Mallory M., Alford M., Hansen L.A., Saitoh T. Immunoreactivity of the nuclear antigen p105 is associated with plaques and tangles in Alzheimer's disease. Lab. Invest. 69:1993;562-569.
2. Smith T.W., Lippa C.F. Ki-67 immunoreactivity in Alzheimer's disease and other neurodegenerative disorders. J. Neuropathol. Exp. Neurol. 54:1995;297-303.
3. Vincent I., Rosado M., Davies P. Mitotic mechanisms in Alzheimer's disease? J. Cell Biol. 132:1996;413-425.
4. Li J., Xu M., Zhou H., Ma J., Potter H. Alzheimer presenilins in the nuclear membrane, interphase kinetochores, and centrosomes suggest a role in chromosome segregation. Cell. 90:1997;917-927.
5. McShea A., Harris P.L.R., Webster K.R., Wahl A.F., Smith M.A. Abnormal expression of the cell cycle regulators p16 and cdk4 in Alzheimer's disease. Am. J. Pathol. 150:1997;1933-1939.
6. Nagy Z., Esiri M.M., Smith A.D. Expression of cell division markers in the hippocampus in Alzheimer's disease and other neurodegenerative conditions. Acta Neuropathol. 93:1997;294-300.
7. Nagy Z., Esiri M.M., Cato A.M., Smith A.D. Cell cycle markers in the hippocampus in Alzheimer's disease. Acta Neuropathol. 94:1997;6-15.
8. Ledesma M.D., Correas I., Avila J., Diaz-Nido J. Implication of brain cdc2 and MAP2 kinases in the phosphorylation of tau protein in Alzheimer's disease. FEBS Lett. 308:1992;218-224.
9. McShea A., Zelasko D.A., Gerst J.L., Smith M.A. Signal transduction abnormalities in Alzheimer's disease: evidence of a pathogenic stimuli. Brain Res. 815:1999;237-242.
10. Shirvan A., Ziv I., Machlin T., Zilkha-Falb R., Melamed E., Barzilai A. Two waves of cyclin B and proliferating cell nuclear antigen expression during dopamine-triggered neuronal apoptosis. J. Neurochem. 69:1997;539-549.
11. Chuang T.H., Hahn K.M., Lee J.D., Danley D.E., Bokoch G.M. The small GTPase Cdc42 initiates an apoptotic signaling pathway in Jurkat T lymphocytes. Mol. Biol. Cell. 8:1997;1687-1698.
12. Hall A. Rho GTPases and the actin cytoskeleton. Science. 279:1998;509-514.
13. Olson M.F., Ashworth A., Hall A. An essential role for Rho, Rac and Cdc42 GTPases in cell cycle progression through G1. Science. 269:1995;1270-1272.
14. Khosravi-Far R., Solski P.A., Clark G.J., Kinch M.S., Der C.J. Activation of Rac1, RhoA, and mitogen-activated protein kinase is required for Ras transformation. Mol. Cell Biol. 15:1995;6443-6453.
15. Qiu R.G., Chen J., Kirn D., McCormick F., Symons M. An essential role for Rac in Ras transformation. Nature. 374:1995;457-459.
16. Qiu R.G., Abo A., Mccormick F., Symons M. Cdc42 regulates anchorage-independent growth and is necessary for Ras transformation. Mol. Cell Biol. 17:1997;3449-3458.
17. Cano E., Mahadevan L.C. Parallel signal processing among mammalian MAPKs. Trends Biochem. Sci. 20:1995;117-122.
18. Coso O.A., Chiariello M., Yu J.C., Teramoto H., Crespo P., Xu N., Miki T., Gutkind J.S. The small GTP-binding proteins Rac1 and Cdc42 regulate the activity of JNK/SAPK signaling pathway. Cell. 81:1995;1137-1146.
19. Frisch S.M., Vuori K., Kelaita D., Sicks S. A role for Jun-N-terminal kinase in anoikis: suppression by bcl-2 and crmA. J. Cell Biol. 135:1996;1377-1382.
20. Goillot E., Raingeaud J., Ranger A., Tepper R.I., Davis R.J., Harlow E., Sanchez I. Mitogen-activated protein kinase-mediated Fas apoptotic signaling pathway. Proc. Natl. Acad. Sci., USA. 94:1997;3302-3307.
21. Zanke B.W., Boudreau K., Rubie E., Winnett E., Tibbles L.A., Zon L., Kyriakis J., Liu F.F., Woodgett J.R. The stress-activated protein kinase pathway mediates cell death following injury induced by cis-platenum, UV irradiation or heat. Curr. Biol. 6:1996;606-613.
22. Verheij M., Ruiter G.A., Zerp S.F., van Blitterswijk W.J., Fuks Z., Haimovitz-Friedman A., Bartelink H. The role of the stress-activated protein kinase (SAPK/JNK) signaling pathway in radiation-induced apoptosis. Radiotherapy Oncology. 47:1998;225-232.
23. Bazenet C.E., Mota M.A., Rubin L.L. The small GTP-binding protein Cdc42 is required for nerve growth factor withdrawal-induced neuronal death. Proc. Natl. Acad. Sci., USA. 95:1998;3984-3989.
24. Grundke-Iqbal I., Iqbal K., Tung Y.C., Quinlan M., Wisniewski H.M., Binder L.I. Abnormal phosphorylation of the microtubule-associated protein τ (tau) in Alzheimer cytoskeletal pathology. Proc. Natl. Acad. Sci., USA. 83:1986;4913-4917.
25. Smith M.A., Rudnicka-Nawrot M., Richey P.L., Praprotnik D., Mulvihill P., Miller C.A., Sayre L.M., Perry G. Carbonyl-related posttranslational modification of neurofilament protein in the neurofibrillary pathology of Alzheimer's disease. J. Neurochem. 64:1995;2660-2666.
26. Perry G., Nunomura A., Smith M.A. A suicide note from Alzheimer disease neurons? (News and Views). Nature Med. 4:1998;897-898.
27. Perry G., Nunomura A., Lucessen P., Lassmann H., Smith M.A. Apoptosis and Alzheimer's disease. Science (Letter). 282:1998;1268-1269.
28. Khachaturian Z.S. Diagnosis of Alzheimer's disease. Arch. Neurol. 42:1985;1097-1105.
29. Mirra S.S., Heyman A., McKeel D., Sumi S.M., Crain B.J., Brownlee L.M., Vogel F.S., Hughes J.P., van Belle G., Berg L. The consortium to establish a registry for Alzheimer's disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology. 41:1991;479-486.
30. Sternberger L.A. Immunocytochemistry. 3rd ed. 1986;Wiley, New York.
31. Smith M.A., Kutty R.K., Richey P.L., Yan S.-D., Stern D., Chader G.J., Wiggert B., Petersen R.B., Perry G. Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer's disease. Am. J. Pathol. 145:1994;42-47.
32. Bush J., Franek K., Cardelli J. Cloning and characterization of seven novel Dictyostelium discoideum rac-related genes belonging to the rho family of GTPases. Gene. 136:1993;61-68.
33. Giasson B.I., Mushynski W.E. Aberrant stress-induced phosphorylation of perikaryal neurofilaments. J. Biol. Chem. 271:1996;30,404-30,409.
34. Julien J.P., Mushynski W.E. Neurofilaments in health and disease. Prog. Nucleic Acid Res. Mol. Biol. 61:1998;1-23.
35. Perry G., Rizzuto N., Autilio-Gambetti L., Gambetti P. Paired helical filaments from Alzheimer disease patients contain cytoskeletal components. Proc. Natl. Acad. Sci., USA. 82:1985;3916-3920.
36. Kyriakis J.M., Avruch J. Protein kinase cascades activated by stress and inflammatory cytokines. Bioessays. 18:1996;567-577.
37. Goedert M., Hasegawa M., Jakes R., Lawler S., Cuenda A., Cohen P. Phosphorylation of microtubule-associated protein tau by stress-activated protein kinases. FEBS Lett. 409:1997;57-62.
38. Reynolds C.H., Nebreda A.R., Gibb G.M., Utton M.A., Anderton B.H. Reactivating kinase/p38 phosphorylates tau protein in vitro. J. Neurochem. 69:1997;191-198.
39. Iqbal K., Zaidi T., Thompson C.H., Merz P.A., Wisniewski H.M. Alzheimer paired helical filaments: bulk isolation, solubility, and protein composition. Acta Neuropathol. 62:1984;167-177.
40. Boivin D., Bilodeau D., Beliveau R. Regulation of cytoskeletal functions by Rho small GTP-binding proteins in normal and cancer cells. Canad. J. Physiol. Pharmacol. 74:1996;801-810.
41. Chiariello M., Visconti R., Carlomagno F., Melillo R.M., Bucci C., de Franciscis V., Fox G.M., Jing S., Coso O.A., Gutkind J.S., Fusco A., Santoro M. Signalling of the Ret receptor tyrosine kinase through the c-Jun NH2-terminal protein kinases (JNKs): evidence for a divergence of the ERKs and JNKs pathways induced by Ret. Oncogene. 16:1998;2435-2445.
42. Hill C.S., Wynne J., Treisman R. The Rho family GTPases RhoA, Rac1, and Cdc42Hs regulate transcriptional activation by SRF. Cell. 81:1995;1159-1170.
43. Westwick J.K., Lambert Q.T., Clark G.J., Symons M., Van Aelst L., Pestell R.G., Der C.J. Rac regulation of transformation, gene expression, and actin organization by multiple, PAK-independent pathways. Mol. Cell Biol. 17:1997;1324-1335.
44. Tjandra H., Compton J., Kellogg D. Control of mitotic events by the Cdc42 GTPase, the Clb2 cyclin and a member of the PAK kinase family. Curr. Biol. 8:1998;991-1000.
45. McShea A., Wahl A. F. and Smith M. A., Re-entry into the cell cycle: A mechanism for neurodegeneration in Alzheimer disease. Med Hypotheses, 1999, 52, 525-527.